{
    "clinical_study": {
        "@rank": "102617", 
        "arm_group": {
            "arm_group_label": "Sulfamethoxazole-trimethoprim treatment"
        }, 
        "brief_summary": {
            "textblock": "In this study, we aim to investigate the incidence of the adverse reactions, the\n      effectiveness and the gene polymorphism associated with the plasma level of\n      sulfamethoxazole-trimethoprim and their metabolites (including N4-acetyl-sulfamethoxazole,\n      sulfamethoxazole hydroxylamine and sulfamethoxazole-nitroso). And we also aim to investigate\n      the factors associated with the sulfamethoxazole-trimethoprim induced acute psychosis."
        }, 
        "brief_title": "A Pharmacokinetic and Pharmacogenetic Study in Patients Receiving Sulfamethoxazole-trimethoprim Therapy", 
        "completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Pneumocystis Jiroveci Pneumonia", 
        "condition_browse": {
            "mesh_term": [
                "Pneumonia", 
                "Pneumonia, Pneumocystis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  males and females aged 20 years or older\n\n          -  using oral or intravenous form of sulfamethoxazole-trimethoprim\n\n        Exclusion Criteria:\n\n          -  patients who are under 20 years of age"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients who are treated in the National Taiwan University Hospital"
            }
        }, 
        "enrollment": {
            "#text": "1000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 17, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02045160", 
            "org_study_id": "201312090RINC"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Sulfamethoxazole", 
                "Trimethoprim", 
                "Trimethoprim-Sulfamethoxazole Combination"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "January 22, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Taipei", 
                        "country": "Taiwan", 
                        "state": "TW", 
                        "zip": "106"
                    }, 
                    "name": "National Taiwan University Hospital"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "email": "r01451004@ntu.edu.tw", 
                    "last_name": "Jin-Han Yang"
                }, 
                "facility": {
                    "address": {
                        "city": "Taipei", 
                        "country": "Taiwan", 
                        "state": "TW", 
                        "zip": "106"
                    }, 
                    "name": "National Taiwan University Hospital"
                }, 
                "investigator": {
                    "last_name": "Shu-Wen Lin", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Taiwan"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Pharmacokinetic and Pharmacogenetic Study in Patients Receiving Sulfamethoxazole-trimethoprim Therapy", 
        "overall_contact": {
            "email": "r01451004@ntu.edu.tw", 
            "last_name": "Jin-Han Yang, Bachelor", 
            "phone": "0975-103-277"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Taiwan: Research Ethics Committee"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The plasma concentration will not be measured until the patient's treatment course completed.", 
            "measure": "High performance liquid chromatography for drug plasma concentration", 
            "safety_issue": "Yes", 
            "time_frame": "Participants will be followed for the duration of the treatment course, an expected average of 21 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02045160"
        }, 
        "responsible_party": {
            "investigator_affiliation": "National Taiwan University Hospital", 
            "investigator_full_name": "National Taiwan University Hospital", 
            "investigator_title": "National Taiwan University Hospital", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "National Taiwan University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Taiwan University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}